The market across Asia-Pacific is expected to register the highest CAGR of 6.0% from 2019 to 2026.

PORTLAND, OREGON, US, November 16, 2021 /EINPresswire.com/ -- According to the report, the global uveitis treatment market was pegged at $500.7 million in 2019 and is expected to reach $687.4 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.

Chief reasons for market fluctuations

Rise in prevalence of uveitis, potential drugs in pipeline, and surge in healthcare expenditure worldwide drive the growth of the global uveitis treatment market. However, unknown etiology of uveitis hampers the market growth. On the contrary, higher number of unmet needs for treatment of uveitis and growing prospects in emerging market are expected to create lucrative opportunities in the near future.

Detail Insights at: https://www.alliedmarketresearch.com/uveitis-treatment-market-A05994

The anti-inflammatory segment held the largest share

The anti-inflammatory segment dominated the global uveitis treatment market in 2019, accounting for nearly two-fifths of the market, owing to easy accessibility of the drugs, increase in prevalence of uveitis, and preferable usage of anti-inflammatory in treatment of the disease. However, the immunotherapy and targeted therapies segment is projected to register the fastest CAGR of 5.8% during the forecast period, owing to cost effectiveness, rise in adoption of immunotherapy and targeted therapies for treatment of severe uveitis, and increase in R&D activities.

The online pharmacies segment to portray fastest growth through 2026

The online pharmacies segment is anticipated to manifest the fastest CAGR of 5.9% during the study period, owing to rise in preference for online purchasing of drugs over the traditional methods, increase in awareness of online pharmacies, and surge in number of Internet users. However, the drug stores & retail pharmacies segment held the largest share in 2019, accounting for nearly three-fifths of the global uveitis treatment market. This is due to increase in number of uveitis patients, surge in number of hospital pharmacies, improvement in structure of hospital pharmacies in the emerging countries such as China and India.

North America held the largest share

The global uveitis treatment market across North America held the largest share in 2019, accounting for more than two-fifths of the market, due to higher prevalence of uveitis, higher healthcare awareness, presence of well-developed healthcare infrastructure and trained medical professionals, and easy accessibility to the therapeutics. However, the market across Asia-Pacific is expected to register the highest CAGR of 6.0% from 2019 to 2026, owing to high population base, growth in prevalence of uveitis treatment systems, and increase in demand for uveitis therapeutics.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6359

Major market players

AbbVie Inc.
Allergan Plc.
Alimera Sciences, Inc.
Bausch Health Companies Inc. (Bausch & Lomb Incorporated)
Amgen Inc.
EyePoint Pharmaceuticals, Inc.
Clearside Biomedical, Inc.
Novartis AG
Mylan N.V.
Santen Pharmaceutical Co., Ltd.

Similar Report:

Central Nervous Disorders Industry Forecast
Body Temperature Monitoring Market Opportunity Analysis
Lung injury Market Industry Forecast | 2021–2030

About Us:

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+ +1 8007925285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.